glp 1 and liver disease GLP-1 Receptor Agonist Non-Alcoholic Fatty Mechanism of action for GLP-1R
Description
The improvement of IIH with GLP-1 RAs is promising, but prospective, randomized controlled trials with larger cohorts are needed
Control Release 211 , 144162 (2015)
These findings suggest that GLP-1 RAs could play a crucial role in the management of HFpEF, particularly in patients with obesity, by targeting the underlying inflammatory processes and contributing to better overall cardiovascular outcomes
They help treat diabetes and weight loss
